These pages use javascript to create fly outs and drop down navigation elements.

Seattle Angina Questionnaire (SAQ)

Please note that this section is an archive (last updated in June 2006). [disclaimer]

Sections:   Overview | Instrument Reviews | Construct Overviews | Book Compendium Reviews | Internet Site Reviews

Created 2004 January 15
Jump To A Section

Practical Information | Research Contacts | Annotated Bibliography | Factors & Norms | Reliability Evidence | Validity Evidence | Comments | Updates | Feedback

Practical Information

Instrument Name:

Seattle Angina Questionnaire (SAQ)

Instrument Description:

There are no widely accepted measures assessing the functional status of those with coronary disease. (Ref: 1) Spertus et al. mentions that the optimal measure should quantify the routine exertion level of the patient, the frequency of angina, the patient’s satisfaction with the treatment regime, and the quality of life limitations caused by coronary disease (patient perspective). (Ref: 1) The Seattle Angina Questionnaire (SAQ) addresses these concerns, specifically focusing on quantifying angina-related physical and emotional effects. (Ref: 1)

The SAQ is a self-administered questionnaire, consisting of 19 items and 5 scales. (Ref: 1) The constructs, or scales, addressed in the measure are: disease perception, treatment satisfaction, physical limitation, angina stability and anginal frequency. The physical limitation scale was derived from various scales and the angina frequency scale was adopted from the Angina Questionnaire. (Ref: 1)

The physical limitation scale presents items beginning with simple activities and progresses to more extraneous tasks. Degree of limitation is due to “chest pain, chest tightness, or angina” The physical limitation scale has responses ranging from “severely limited” to “not limited,” plus a “did not do for other reasons” response. The angina stability scale is a single item measuring the occurrence(s) of angina at the patient’s most extraneous activity level obtained and compared to occurrences four weeks prior. The angina stability scale utilizes a 5-point system ranging from “much more often” to “much less often”. The angina frequency scale consists of two items and utilizes a 6-point scale ranging from “four or more occurrences” to “no occurrences.” Treatment satisfaction is measured by four items on a 5-point scale with responses ranging from dissatisfaction with treatment to a patient-perceived satisfaction with treatment. Lastly, disease perception is measured by three items on a 5-point scale with responses ranging from a patient-perceived poor quality of life to a patient-perceived better quality of life.

Price:

$125; Available at the website under

Administration Time:

The questionnaire takes less than 5 minutes to complete. (Ref: 1,3)

Publication Year:

1995 (original articles were published in 1994)

Item Readability:

The Flesch-Kincaid reading grade level is 8.1, indicating that subjects completing the 8th grade can understand the questionnaire. There is an average of 20 words per item and no negatively worded items.

Scale Format:

Items in the SAQ have ordinal (Likert-type) responses, ranging from one extreme to the other. The scales range from 5-point response systems to 6-point response systems.

Administration Technique:

Self-administered. (Ref: 1)

Scoring and Interpretation:

Responses in the SAQ are given ordinal values. Items that correspond to the lowest level of functioning are assigned a value of one, while items that correspond to higher functioning levels are assigned a higher ordinal value. These scores are converted to a 100-point score by subtracting the lowest possible scale score, dividing it by the response range and multiplying it by 100. Generally, a higher score indicates the patient’s ability to exert higher functional levels. Each scale measures and consists of its own score descriptions. (Ref: 1) There is no total instrument score. One study defined the interpretation of the angina frequency and physical limitation scores as severe (0-24), moderate (25-49), mild (50-74) and minimal (75-100). Angina frequency ranges from severe (several times per day) to minimal angina (less than once a week). Angina stability scores range from much better (100-76) to poor (24-0). (Ref: 6) Lastly, for the treatment satisfaction and disease perception scales, higher scores indicate high treatment satisfaction and disease perception.

Forms:

This questionnaire is available in multiple languages including English, French, Danish, Dutch, French, Italian, Norweigian, Swedish and Spanish. Refer to the SAQ ordering website for further details (http://www.outcomes-trust.org).

Research Contacts

Instrument Developers:

John A Spertus, MD, MPH

Instrument Development Location:

No information found.

The SAQ is available at http://www.outcomes-trust.org.

Instrument Developer Email:

jspertus@cctr.umkc.edu

Instrument Developer Website:

Annotated Bibliography

1. Spertus JA, Development and evaluation of the Seattle Angina questionnaire: a new functional status measure for coronary artery disease. J Amer Coll Cardiol 1995 Feb;25(2):333-41. [PMID: 7829785]
Purpose: To discuss the development of the SAQ and its reliability and validity.
Sample: There were four patient groups formed to determine the validation of the SAQ scales. The first group comprised of 70 patients with coronary disease undergoing a treadmill test. The mean age was 61 years, and 95% were male. The second group comprised of outpatients with self-reported coronary artery disease. This group consisted of 84 subjects (those that completed the needed surveys). The mean age was 67 years and 95% were male. The third group consisted of patients with initially stable coronary artery disease. The sample size totaled 117 after exclusion of 17 subjects. The mean age was 69 years and 97% were men. The fourth group was those undergoing percutaneous coronary angioplasty. The final sample size consisted of 45 subjects, with a mean age of 60.2 years and 87% were male.
Methods: Subjects of the first group were recruited from the Veterans Affairs Medical Center and a university-affiliated outpatient clinic that had abnormal treadmill results. Coronary heart disease was present if the patient previously had myocardial infarction, a previous revascularization procedure or angiogram documenting coronary disease or chest pain and abnormal treadmill results. Patients were required to complete three questionnaires in random order. Patients enrolled in the first 6 weeks of the study completed the SAQ, the Duke Activity Status Index (DASI) and the Specific Activity Scale (SAS). Those enrolled in the second half of the study took the SAQ, the DASI and the SF36 (instead of the SAS).

The second group of subjects was identified, and received the SAQ and the American Board of Internal Medicine’s Patient Satisfaction Questionnaire by mail. No further information was provided for this group. The third group of subjects was recruited from the Seattle Veterans Affairs Medical Center. To qualify for the study, patients needed a discharge diagnosis of coronary disease within the previous five years, a current prescription of nitroglycerine, no change in antianginal medications within the past 9 months, no hospitalizations within the past 2 months or no diagnostic tests indicating cardiac disease status during the past 2 months. SAQ and the SF 36 were mailed to the subjects. Subjects were given a follow up call if the mailed questionnaires were not filled out within a certain period. Lastly, the fourth group was recruited from the Veterans Affairs Medical Center and helped determine the responsiveness of the SAQ to clinical change.
Implications: When the SAQ was compared to other scales measuring a patient’s exertional capacity, the strengths and limitations of the SAQ were apparent. The author noted that the SAQ measures a broader range of disease effects. Furthermore, the questionnaire discusses activity limitations specific to coronary disease. A limitation that the scale presents is a low correlation in validating the angina frequency scale. Medication refills was not indicative of angina frequency because patients may not have used medication with every angina episode. Medication refills does help estimate medication use, and hence treatment satisfaction.

2. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Fihn SD. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994 Dec 15; 74(12):1240-4. [PMID: 7977097]
Purpose: This study compares the responsiveness of the SAQ and SF-36 in monitoring patients with coronary artery disease.
Sample: Patients were recruited from the Veterans Affairs medical Center in Seattle with a mean age of 60 years. The majority of the participants were male (84%).
Methods: Two groups of patients were selected for analysis, those successfully undergoing coronary angioplasty and patients who have initially stable coronary artery disease. Recruited patients were excluded from the study if they were hypotensive, intubated or unable to speak English. Inclusion criteria for the stable group were diagnosed with coronary artery disease, had a current prescription of nitroglycerine, did not have a change in medication within the last 9 months, were not hospitalized or underwent a diagnostic evaluation of cardiac disease within the past two months. All subjects received the SAQ and the SF-36 and were reevaluated by the same measures after three months.
Implications: Researchers found that the SAQ, a disease-specific measure, was more sensitive to change than the SF-36, a general functional status measure. All SAQ scales, except for the treatment satisfaction scale, resulted in significant changes. The treatment satisfaction score, unchanged, reflects the high level of satisfaction before and after the angioplasty procedure. These findings indicate that the selection of functional status measures depend on the focus of the research. If coronary artery disease is the topic of interest, SAQ may be the measure of choice. However, if an investigator is studying patients’ general health, a combination of SAQ and SF-36 may be chosen.

3. Dougherty CM, Dewhurst T, Nichol WP, Spertus J. Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III. J Clin Epidemiol 1998; 51(7):569-75. [PMID: 9674663]
Purpose: To compare the psychometric properties of three quality of life instruments, SAQ, SF-36 and Quality of Life Index (QLI), with the Canadian Cardiovascular Society Classification (CCSC) (gold standard) in patients with angina concerns.
Sample: Participants totaled 107, with a mean age of 65 years. The patients were all men, mostly Caucasian (79.4%). A large percentage of individuals had co-morbidities, such as hypertension, depression, diabetes mellitus and so forth. Most of the patients were categorized as CCSC Class I or Class II and a large portion were taking calcium antagonists (90.6%), nitrites (80.4%) or beta blockers (52.3%).
Methods: Subjects were recruited from the Veterans Affairs Medical Center in Pacific Northwest to participate in a Quality of Life and Angina Research Trial (QUART). Individuals were selected if they were diagnosed with angina and took at least two angina medications regularly, spoke English and were available to be followed up. Individuals were excluded if hospitalization occurred less than four months prior to the trial, had ejection fraction below 40% or aortic stenosis, extensive heart blockage or other life threatening co-morbidities. Eligible patients received the aforementioned questionnaires at the time of enrollment and a nurse practitioner categorized participants in the appropriate CCSC category. Patients were followed up with the same questionnaires 2-weeks from enrollment, a once monthly for three months.
Implications: Researchers found that the SAQ identified deterioration of health status with patients categorized with high CCSC classes. The three measures were all reliable with respects to test-retest results, but were substantially different in regards to responsiveness scores. The SAQ was the most responsive measure to angina, while the SF-36 better detects a broader category of patients’ functional status and the QLI excels in determining the patients’ quality of life.

4. MacDonald P, Stadnyk K, Cossett J, Klassen G, Johnstone D, Rockwood K. Outcomes of coronary artery bypass surgery in elderly people. Can J Cardiol 1998 Oct; 14(10):1215-22. [PMID: 9852935]
Purpose: To study the impact of Coronary Artery Bypass surgery (CABG) on patients’ quality of life and responsive evidence on the SAQ.
Sample: There were 100 participants in the study with a mean age of 78.8, 66% were male.
Methods: Patients, who were 75 and older, undergoing CABG, were recruited from the Victoria General Hospital. Demographic, clinical and medication information were obtained from the participants. Patients received various quality of life measures at the time of recruitment and three months and one year after recruitment.
Implications: The study found that the SAQ was more responsive than RAND in detecting clinically important change in quality of life indicators. Furthermore, within the three-month time span, subjects over 80 years were less likely to improve in physical function. Those that improved in physical function, likely improved in social function, provided that the disease limited the social interaction and normal conditions improved social interactions. Lastly, the study noted that coronary revascularization will continue to be the treatment of choice for the aging population with ischemic heart disease.

5. Spertus JA, Dewhurst T, Dougherty CM, Nichol P. Testing the effectiveness of converting patients to long-acting antianginal medications: The Quality of Life in Angina Research Trial (QUART). Am Heart J 2001 Apr; 141(4):550-8. [PMID: 11275919]
Purpose: Researchers hypothesized that switching patients with stable angina to long-term antianginal medication would enhance treatment satisfaction, quality of life, functional status and symptom control. This study was designed to evaluate this hypothesis.
Sample: This study contained 100 participants with stable coronary disease. No age or ethnic percentages were mentioned.
Methods: Patients were recruited from the Veterans Affairs Medical Center through pharmacy database screening and alerting clinicians treating the population of interest. Individuals were selected if they were diagnosed with chronic stable angina and took at least two angina medications regularly to control angina symptoms. Individuals were excluded if hospitalization occurred less than four months prior to the trial, had ejection fraction below 40% or aortic stenosis, extensive heart blockage or other life threatening co-morbidities. Eligible patients were randomly selected into two groups. One group had optimal adjustments made to their usual medications and the other group was given long-acting medications. Patients were assessed by the SAQ and SF-36 after 2-weeks and once monthly for three months. This follow up sessions helped in determining angina symptom stability.
Implications: Primary goals in treating coronary artery disease are controlling symptoms and improving quality of life. This study found improvements in scores of treatment satisfaction, disease-specific quality of life, and symptom control in the group of patients with coronary artery disease treated with long-acting medications. The results of the study adequately support the use of medication once daily as opposed to the shorter-acting medications for anginal symptom control.

6. Spertus JA, Jones P, McDonnell M, Fan V, Fihn SD. Health status predicts long-term outcome in outpatients with coronary disease. Circ 2002 Jul 2; 106(1):43-9. [PMID: 12093768]
Purpose: To evaluate patient perceived functional limitations, quality of life and frequency of angina and its relationship with mortality and hospitalization. The SAQ was used to evaluate the previously mentioned variables.
Sample: The total number of participants in the study was 5558. Of this total, 83% reported coronary artery disease. No information was reported concerning demographics or ethnic percentages of the population.
Methods: Patients enrolled in the Internal Medicine Clinics in six Veterans Affairs Medical Centers were mailed demographic, sociodemographic, medical history and SF-36 questionnaires. Those subjects with medical histories indicating coronary artery disease or angina received the SAQ as well. All patients were followed up for two years to determine outcome results.
Implications: Researchers found that a patient’s health status, with respects to quality of life, physical function and symptoms, was a strong predictor of mortality and hospitalization. Higher SAQ scores were associated with better outcomes as opposed to lower SAQ scores. Furthermore, higher SAQ scores related to survival, enhanced quality assessments and was useful in managing patients with coronary artery disease.

7. Kimble LP, Dunbar SB, Williams SW, McGuire DB, Fazio S, De AK, Strickland O. The Seattle Angina Questionnaire: Reliability and validity in women with chronic stable angina. Heart Disease 2002; 4:206-11. [PMID: 12147179]
Purpose: To determine the psychometric properties of the SAQ in a sample of women with a history of angina
Sample: Participants consisted of 175 women: 72.6% white, 25.7% black and 1.7% other, with an average of 8.3 years of coronary artery disease.
Methods: Women were recruited from three chronic stable angina studies. All subjects were outpatients, treated in facilities associated with large academic health centers. Inclusion criteria involved a history of coronary artery disease and reports of one or more angina episodes within a six-month period. Subjects were excluded from the study if artery bypass grafting was performed on them, or if PTCA or acute myocardial infarction occurred within the past six-months.
Implications: SAQ proved to be a reliable and valid measure for women with coronary artery disease and angina. Researchers found that items of the same scale clustered together; however, there were a few differences in the factor structure of the women sample compared to the original SAQ factor structure. The current study found Factor I (see factor analysis below) to contain two parts: middle and high exertion levels, and had common variances. These items focused on mobility and exercise tolerance. Furthermore, the low exertion level activities shared variances in Factor III. These items involved self-care concerns. Researchers noted that Factor V, item 5, “How bothersome is it for you to take your pills for chest pain, chest tightness or angina as prescribed”, did not measure treatment satisfaction in the SAQ due to its inability to load with any other item in the questionnaire. The absence of this question raised the internal consistency value of the treatment satisfaction scale.

top

Factors and Norms

Factor Analysis Work:

Researchers conducted an exploratory factor analysis and found that five factors contained eigenvalues over one, and accounted for 70.2% of the variance. Single item factor loading had to contain a value of 0.50 or more to be included in a specific factor. (Ref: 7) Factors and variances are presented below:

Factor Description Variance
I Physical Limitation in Activities Requiring Middle to Higher Levels of Exertion 32%
II Treatment Satisfaction 15.4%
III Angina Pattern and Disease Perception 10%
IV Physical Limitation With Activities Requiring Lower Levels if Exertion 7.4%
V Perceptions of How Bothersome It Is to Take Oral Medication for Angina 5.4%

Normative Information Availability:

No information found.

Reliability Evidence

Test-retest:

The SAQ demonstrated stable results in the test-retest calculations over a two-week period, with the exception of the “angina stability scale” score (r=0.33). (Ref: 3) Similarly, Spertus et al. noted stability of mean score of all SAQ scales over a three-month period. P values ranged from 0.1 (angina stability) to 0.77 (treatment satisfaction). (Ref: 1)

Inter-rater:

The SAQ is a self-administered questionnaire; therefore, inter rater reliability does not apply.

Internal Consistency:

Cronbach’s alpha was calculated for the SAQ subscales and results are as follows: physical limitation (0.89), angina frequency (0.87) treatment satisfaction (0.77) and disease perception (0.66). The angina stability scale did not have a score, since it contains only one question. (Ref: 3)

Alternate Forms:

No information found.

Validity Evidence

Construct/ Convergent/ Discriminant:

Researchers compared the SAQ to the SF-36 and the Quality of Life Index-Cardiac Version III (QLI) and found a high level of agreement on similar dimensions. For example, the SAQ physical limitation scale and the physical functioning scale of the SF-36 correlated significantly (r=0.63, p=0.000). The SF-36 physical component scale (r=0.59, p=0.000) and the QLI health and functioning scale correlated with the SAQ physical limitation scale (r=0.46, p=0.000). (Ref: 3)

Criterion-related/ Concurrent/ Predictive:

The Canadian Cardiovascular Society Classification (CCSC) was used as a gold standard in evaluating the SAQ, SF-36 and QLI. (Ref: 3) It was noted that as angina impairment increased, per CCSC, the SAQ scores decreased (with the exception of the treatment satisfaction scale scores). P values are as follows: physical limitation (0.002), angina frequency (0.0001), angina stability (0.0035), treatment satisfaction (0.97) and disease perception (0.005). (Ref: 3) Lastly, another study assessed the relationship between total exercise duration and scores of the SAQ, the Specific Activity Scale and the Duke Activity Status Index. (Ref: 1) Results indicated that the SAQ and DASI scores were significantly related to total exercise duration (r=0.42, p<0.001 & r=0.40, p<0.001 respectively) and with each other (r=0.43, p<0.001). (Ref: 1)

Content:

No information found.

Responsiveness Evidence:

With the implementation of angioplasty, all scores within a 3-month period dramatically improved, with the exception of the treatment satisfaction scores. (Ref: 1-2) Similarly, coronary artery bypass surgery (CABG) yielded similar results in, a three-month time span, with improved scores in all SAQ subscales (p < .0001), except for the treatment satisfaction scale. (Ref: 4) Anginal medication treatments caused a statistically significant change in SAQ scores over the three-month period, P=0.000, except for the physical limitation scale, (p=0.40 (Ref: 3), p=0.82 (Ref: 5)

Scale Application in VA Populations:

Yes. (Ref: 1-3,5-6)

Scale Application in non-VA Populations:

Yes. (Ref: 4,7)

Comments


This is a relatively brief set of subscales with somewhat marginal reliability. However, given the number of items, this might be expected. The exploratory factor analysis (Ref: 7) suggests an alternative scale structure that should be explored further. Given the narrowly defined scope of the measure, it does seem to have greater sensitivity to change and show more responsiveness in patients suffering from angina than other functional status measures used in patients with coronary artery disease. It has been used in numerous studies over the last several years and has repeatedly demonstrated responsiveness. It has shown utility in multiple samples. Although it is too short to be considered as a single outcome, it seems to be a reasonable addition to other measures when examining patients with angina.



Updates

No information found.